During the past decade, Universitatsklinikum Munster, Transplant Hepatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Munster, Transplant Hepatology" are "ATTR-PN" (1 trials), "Familial Amyloid Polyneuropathy" (1 trials) and "Transthyretin-associated Amyloidosis With Polyneuropathy" (1 trials). Many other conditions were trialed in "Universitatsklinikum Munster, Transplant Hepatology" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Munster, Transplant Hepatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fx-1006A" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Munster, Transplant Hepatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinikum Munster, Transplant Hepatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitatsklinikum Munster, Transplant Hepatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Munster, Transplant Hepatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".